X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

期刊標題檢索 CANCER BIOTHER 最新評論: Can't access the website? (2023-11-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS]您好,您是該頁面的第 32050 位訪客。

期刊簡介
期刊名稱CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
LetPub Score
5.3
50 ratings
Rate

Reputation
6.3

Influence
3.8

Speed
8.6

期刊簡稱CANCER BIOTHER RADIO
ISSN1084-9785
E-ISSN1557-8852
h-index55
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.800.6070.555
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Radiology, Nuclear Medicine and Imaging
Q137 / 333
Category: Medicine
Subcategory: Oncology
Q183 / 404
Category: Medicine
Subcategory: Pharmacology
Q175 / 313
Category: Medicine
Subcategory: Cancer Research
Q274 / 230

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.
官方網站http://www.liebertpub.com/overview/cancer-biotherapy-and-radiopharmaceuticals/8/
在線稿件提交http://mc.manuscriptcentral.com/Cancerbiotherapy
開放訪問No
出版商Mary Ann Liebert Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1996
每年文章數27每年文章數趨勢
黃金OA百分比5.17%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3105/189
ONCOLOGYSCIEQ3193/322
PHARMACOLOGY & PHARMACYSCIEQ3188/354
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGSCIEQ278/204
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1084-9785%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: About 95%
參考鏈接
相關期刊 【CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    RADIOLOGYH-index: 271

    CiteScore: 35.20
    Radiologia MedicaH-index: 41

    CiteScore: 14.10
    CLINICAL NUCLEAR MEDICINEH-index: 53

    CiteScore: 2.90
    JOURNAL OF NUCLEAR MEDICINEH-index: 195

    CiteScore: 13.00
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGH-index: 153

    CiteScore: 15.60
    INVESTIGATIVE RADIOLOGYH-index: 103

    CiteScore: 15.10
    Circulation-Cardiovascular ImagingH-index: 83

    CiteScore: 6.30
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSH-index: 228

    CiteScore: 11.00
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICSH-index: 63

    CiteScore: 10.70
    RADIOGRAPHICSH-index: 151

    CiteScore: 8.20
    學科內最受檢索的期刊 頁面查看次數
    MEDICAL PHYSICS173610
    NEUROIMAGE157332
    ULTRASONICS133069
    EUROPEAN RADIOLOGY116328
    RADIOLOGY112482
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICS104045
    EUROPEAN JOURNAL OF RADIOLOGY92886
    HUMAN BRAIN MAPPING83586
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS71236
    JOURNAL OF MAGNETIC RESONANCE IMAGING68277
  •  

    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS] 的評論撰寫評論
作者: 中原永伟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-29 11:13:38 評論於
Can't access the website?
(0) 讚! | 中原永伟

作者: 飞鸿郎


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-15 19:57:36 評論於
Is he asking for a full layer of film or can it be trimmed?
(0) 讚! | 飞鸿郎

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:55:07 評論於
All questions must be answered one by one without omission; try to meet the experimental requirements specified in the comments, and provide reasonable reasons if unable to meet them; literature recommended by reviewers must be cited and thoroughly discussed; be sure to check the corrections made in the initial draft before resubmitting
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:32:39 評論於
After the reviewer has completed scoring the chapter, they need to write a comprehensive review. This usually includes a brief summary of the content of the article, an evaluation of the innovative points made in the article, pointing out any shortcomings in the article, and providing suggestions on how the article should be handled by the editing team
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 20:52:27 評論於
What are the opinions and suggestions of journal editors? What are the opinions and suggestions of reviewers? What are the differences between the two?
(0) 讚! | 平原文波

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 19:18:56 評論於
How to respond to reviewer comments?
(0) 讚! | 北国博达

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-18 19:16:21 評論於
It takes a year to publish! That's too slow, with only 8 articles in one issue
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-09 08:09:43 評論於
Review speed: 2.0 | Submission hit rate: 25.0 
Research focus: Tumor 
Experience sharing: Submitted on March 21, 2021, received the first review comments on May 11, 2021, major revisions, 3 reviewers, 19 questions, excluding editorial format suggestions. Revised on May 25, 2021, received the second review comments on June 8, 2021, supplemented with complete Western blot films and statistical analysis results. Decisively wrote a withdrawal letter on June 9, 2021, why not ask for the films at the beginning and waste so much time. It's a lesson that the experimental films were not kept well. Reminder to everyone, it's important to keep the original Western blot films for experiments!
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-05 20:10:21 評論於
The article is very well-written and not easy to understand
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-02 14:21:32 評論於
Regarding the aspect of honesty in communication
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-02 09:31:01 評論於
Do not give an overview and bioinformatics analysis
(0) 讚! | 星熊雅歌

作者: 月河运馨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-20 11:43:36 評論於
How long is your review cycle? What is the article about? Thank you
(0) 讚! | 月河运馨

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 23:27:06 評論於
Your article quality is okay!
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 23:13:04 評論於
Normal
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 22:54:09 評論於
Bimonthly, very slow
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 18:57:28 評論於
This magazine is too slow
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 18:33:10 評論於
Online submission
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 17:39:41 評論於
Published approximately four months after acceptance
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 15:49:47 評論於
The same goes for me, without giving any reasons, wasting my submission fee
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 15:14:00 評論於
Submitted a rejection in a second
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 13:47:41 評論於
Mine too, too slow
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 12:58:36 評論於
I submitted two articles, one was rejected immediately for being pure nonsense, and the other has been under review for nearly three months and was rejected in the end
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-11 11:35:38 評論於
The review process is too slow
(0) 讚! | 星熊雅歌

作者: 星熊雅歌


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-29 19:03:28 評論於
Yes
(0) 讚! | 星熊雅歌

作者: 不灭阳舒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-24 10:22:49 評論於
Do you accept articles for publication in Pure Life magazine?
(0) 讚! | 不灭阳舒

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*